Company Filing History:
Years Active: 2006
Title: Masatoshi Taniguchi: Innovator in Depsipeptide Compounds
Introduction
Masatoshi Taniguchi is a prominent inventor based in Tsukuba, Japan. He is known for his significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target histone deacetylases (HDAC). His work has implications for the treatment of various diseases, including cancer.
Latest Patents
Taniguchi holds a patent for a depsipeptide compound, which is a novel agent useful for the prevention and treatment of diseases associated with HDAC. This compound exhibits strong HDAC inhibitory activity and effectively inhibits cell proliferation against human cancer cells. The invention is particularly relevant for improving conditions related to histone acetylation, especially in tumor or cell proliferative diseases. He has 1 patent to his name.
Career Highlights
Masatoshi Taniguchi is affiliated with Astellas Pharma GmbH, where he continues to advance research in pharmaceutical innovations. His work has been instrumental in developing therapeutic agents that can significantly impact patient care and treatment outcomes.
Collaborations
Taniguchi has collaborated with notable colleagues, including Koji Nagai and Nobuaki Shindo. These partnerships have fostered a collaborative environment that enhances the research and development of innovative compounds.
Conclusion
Masatoshi Taniguchi's contributions to the field of medicinal chemistry, particularly through his work on depsipeptide compounds, highlight his role as a key innovator in the fight against cancer and other diseases. His ongoing research continues to pave the way for new therapeutic options.